These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 26193384

  • 21. [Allopurinol-induced hypersensitivity syndrome].
    Kinyó A, Lakatos A, Varga A, Gyulai R, Varga E, Bata-Csörgő Z, Kemény L.
    Orv Hetil; 2012 Apr 15; 153(15):586-91. PubMed ID: 22472359
    [Abstract] [Full Text] [Related]

  • 22. [Fatal outcome in allopurinol hypersensitivity syndrome].
    Kluger E.
    Ugeskr Laeger; 1998 Feb 16; 160(8):1179-80. PubMed ID: 9492630
    [Abstract] [Full Text] [Related]

  • 23. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
    Stamp LK, Taylor WJ, Jones PB, Dockerty JL, Drake J, Frampton C, Dalbeth N.
    Arthritis Rheum; 2012 Aug 16; 64(8):2529-36. PubMed ID: 22488501
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions.
    Ng CY, Yeh YT, Wang CW, Hung SI, Yang CH, Chang YC, Chang WC, Lin YJ, Chang CJ, Su SC, Fan WL, Chen DY, Wu YJ, Tian YC, Hui RC, Chung WH, Taiwan Severe Cutaneous Adverse Reaction Consortium.
    J Invest Dermatol; 2016 Jul 16; 136(7):1373-1381. PubMed ID: 26996548
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Allopurinol-induced DRESS syndrome.
    Markel A.
    Isr Med Assoc J; 2005 Oct 16; 7(10):656-60. PubMed ID: 16259349
    [Abstract] [Full Text] [Related]

  • 28. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study.
    Su P, Aw CW.
    Int J Dermatol; 2014 Nov 16; 53(11):1339-45. PubMed ID: 25070588
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol].
    Choi SH, Yang SH, Song YB, Kim HJ, Seo YT, Choi DS, Moon KH, Byun JH, Yu ES.
    Korean J Hepatol; 2005 Mar 16; 11(1):80-5. PubMed ID: 15788888
    [Abstract] [Full Text] [Related]

  • 31. Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study.
    Kim SC, Schneeweiss S, Choudhry N, Liu J, Glynn RJ, Solomon DH.
    Am J Med; 2015 Jun 16; 128(6):653.e7-653.e16. PubMed ID: 25660249
    [Abstract] [Full Text] [Related]

  • 32. Examining the use of allopurinol: Perspectives from recent drug injury relief applications.
    Huang CH, Chu MP, Chen WW.
    J Formos Med Assoc; 2019 Jan 16; 118(1 Pt 2):371-377. PubMed ID: 29941331
    [Abstract] [Full Text] [Related]

  • 33. Allopurinol pharmacogenetics: assessment of potential clinical usefulness.
    Zineh I, Mummaneni P, Lyndly J, Amur S, La Grenade LA, Chang SH, Rogers H, Pacanowski MA.
    Pharmacogenomics; 2011 Dec 16; 12(12):1741-9. PubMed ID: 22118056
    [Abstract] [Full Text] [Related]

  • 34. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study.
    Ko TM, Tsai CY, Chen SY, Chen KS, Yu KH, Chu CS, Huang CM, Wang CR, Weng CT, Yu CL, Hsieh SC, Tsai JC, Lai WT, Tsai WC, Yin GD, Ou TT, Cheng KH, Yen JH, Liou TL, Lin TH, Chen DY, Hsiao PJ, Weng MY, Chen YM, Chen CH, Liu MF, Yen HW, Lee JJ, Kuo MC, Wu CC, Hung SY, Luo SF, Yang YH, Chuang HP, Chou YC, Liao HT, Wang CW, Huang CL, Chang CS, Lee MT, Chen P, Wong CS, Chen CH, Wu JY, Chen YT, Shen CY, Taiwan Allopurinol-SCAR Consortium.
    BMJ; 2015 Sep 23; 351():h4848. PubMed ID: 26399967
    [Abstract] [Full Text] [Related]

  • 35. Allopurinol Induced DRESS Syndrome.
    Pawar P, Gupta VA, Karnik ND, Vaidya M, Khopkar U.
    J Assoc Physicians India; 2014 Nov 23; 62(11):63-5. PubMed ID: 26281488
    [Abstract] [Full Text] [Related]

  • 36. Real-world evidence of population differences in allopurinol-related severe cutaneous adverse reactions in East Asians: A population-based cohort study.
    Sato T, Cheng CL, Park HW, Kao Yang YH, Yang MS, Fujita M, Kumagai Y, Tohkin M, Saito Y, Sai K.
    Clin Transl Sci; 2021 May 23; 14(3):1002-1014. PubMed ID: 33382928
    [Abstract] [Full Text] [Related]

  • 37. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin.
    Chung WH, Chang WC, Stocker SL, Juo CG, Graham GG, Lee MH, Williams KM, Tian YC, Juan KC, Jan Wu YJ, Yang CH, Chang CJ, Lin YJ, Day RO, Hung SI.
    Ann Rheum Dis; 2015 Dec 23; 74(12):2157-64. PubMed ID: 25115449
    [Abstract] [Full Text] [Related]

  • 38. Allopurinol hypersensitivity syndrome: a review.
    Arellano F, Sacristán JA.
    Ann Pharmacother; 1993 Mar 23; 27(3):337-43. PubMed ID: 8453174
    [Abstract] [Full Text] [Related]

  • 39. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
    Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Pérez de Jose A, Cedeño S, Linares T, Luño J.
    Am J Kidney Dis; 2015 Apr 23; 65(4):543-9. PubMed ID: 25595565
    [Abstract] [Full Text] [Related]

  • 40. [Hyperuricemia: caution before treating Asians with allopurinol].
    Blondel N.
    Rev Med Suisse; 2015 Dec 09; 11(498):2352. PubMed ID: 26790249
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.